Efficacy Assessment of Meloxicam, a Preferential Cyclooxygenase-2 Inhibitor, in Acute Coronary Syndromes Without ST-Segment Elevation. The Nonsteroidal Anti-Inflammatory Drugs in Unstable Angina Treatment-2 (NUT-2) Pilot Study - NUT-2


The goal of this study was to assess the safety and efficacy of the combination of Meloxicam with heparin and aspirin superior to heparin and aspirin alone among patients with Non-ST-elevation acute coronary syndrome